Oxford vaccine: Serum to apply for emergency-use authorisation in 2 weeks

Pune-based Serum Institute of India (SII) would apply to the Indian drug regulator within the next two weeks for emergency-use authorisation of the Oxford-AstraZeneca vaccine, Chief Executive Adar Poonawalla said on Saturday after Prime Minister PM Narendra Modi’s visit to the Serum plant.
 
"As of now, we don't have anything in writing with the Government of India on how many doses they would purchase, but the indication is that 300-400 million doses might be procured by July 2021," Poonawalla told reporters. "We are in the process of applying in the next two weeks for emergency-use authorisation."